SELLAS Life Sciences Group, Inc.: cash_and_restricted_cash

Value{"amount": 14352000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"}
Period (as of 2022-03-31)
Statuscurrent
EntitySELLAS Life Sciences Group, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001390478-22-000012 · Open the official SEC filing →
Retrieved: 2026-08-19T13:26:28.412177+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001390478/cash-and-restricted-cash/2022-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/2df3ce4e-7f6c-4f01-b2f0-3f97d5797d76

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies